Trial intelligence / Profile preview

SMAC Artesunate Follow-Up Study

PACTR201102000277177Unknown

Sponsor
Prof. Peter Kremsner
Start
May 2011
Modality
Small Molecules
Countries
5
01

Overview

Trial of artesunate in Malaria (2 arms), sponsored by Prof. Peter Kremsner. Primary endpoint: Parasite clearance at 24 hours. Status: unknown.

02

Drugs

artesunate
03

Conditions

Malaria

Beyond the preview

Go deeper on PACTR201102000277177.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201102000277177.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call